NEW EVENT! ZEPZELCA in combination with atezolizumab in ES-SCLC ~ Thursday, 11/6/25Oct 16, 20251 min readInterested!? Email Aimee directly at aimee.ferry@jazzpharma.com or give her ring!
NEW Event! From Mutation to Management: Practical Nursing Strategies in HER2-Mutant NSCLC ~ 5.14.26 @ ONS Congress
Management of high-risk non-melanoma skin cancers (NMSC)Dear BONS Membes, I’d like to invite you to join a Dana-Farber–anchored, multidisciplinary CME activity focused on the management of high-risk non-melanoma skin cancers (NMSC)—including BCC, cSCC, and
Comments